J Biol Chem (2008) 283(13):872335.10.1074/jbc.M706105200 45 WinklerDGSutherlandMKGeogheganJCYuCHayesTSkonierJEet alOsteocyte control of bone formation via sclerostin, a novel BMP antagonist
After some time in the Department of Medical Anatomy at the University of Copenhagen, rskov joined Novo Nordisk in 2007 where she became involved in developing new GLP-1 based drugs
Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
They were bypassed
The posttreatment selection of patients for the biomarker analyses was thus affected by the timing of followup measurements, reflecting disease progression and patient behavior, limiting the interpretation of the changes in biomarker values
Curr Opin Pulm Med